Sumitomo Pharma America Holdings, Inc. is a leading pharmaceutical company dedicated to improving global health and well-being. With a focus on critical areas such as psychiatry, neurology, oncology, urology, women's health, rare diseases, and cell gene therapy, they drive innovation in treatments, science, and technology to address patient needs.
As an innovation growth engine, Sumitomo Pharma America combines technology and life-sciences expertise to accelerate drug discovery, development, and commercialization, aiming to deliver patient-first solutions sooner. With a diverse pipeline of preclinical and clinical programs, they are committed to fueling breakthroughs and improving patient outcomes through a technology-driven approach.
Generated from the website